Merck & Co., Inc.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
12
Total Value
164284061
Accession Number
0000064978-25-000005
Form Type
13F-HR
CIK
0000310158
Manager Name
Merck & Co., Inc.
Data Enrichment
75% identified
9 identified3 unidentified

Holdings

12 positions
Manager:
SEC
Search and click to pin securities to the top
Moderna, Inc.
MRNA|60770K107
Shares:
2308190(+0.0%)
Value:
$65.4B(-31.8%)
Personalis, Inc.
PSNL|71535D106
Shares:
14044943(+0.0%)
Value:
$49.3B(-39.3%)
Kymera Therapeutics, Inc.
KYMR|501575104
Shares:
772165(+0.0%)
Value:
$21.1B(-32.0%)
29384C908
29384C908
Shares:
1739768(+0.0%)
Value:
$15.7B(-47.7%)
Alector, Inc.
ALEC|014442107
Shares:
3545719(+0.0%)
Value:
$4.4B(-34.9%)
29970R204
29970R204
Shares:
1214126(+123.9%)
Value:
$2.2B(+389.9%)
SUTRO BIOPHARMA, INC.
STRO|869367102
Shares:
2723509(+0.0%)
Value:
$1.8B(-64.6%)
LAVA Therapeutics NV
LVTX|N51517105
Shares:
1149345(+0.0%)
Value:
$1.5B(+33.5%)
Viridian Therapeutics, Inc.\DE
VRDN|92790C104
Shares:
93414(+0.0%)
Value:
$1.3B(-29.7%)
Xilio Therapeutics, Inc.
XLO|98422T100
Shares:
1483758(+0.0%)
Value:
$1.1B(-24.1%)
Carisma Therapeutics Inc.
CARM|14216R101
Shares:
1473240(+0.0%)
Value:
$456.7M(-26.0%)
64136E102
64136E102
Shares:
10027(+0.0%)
Value:
$57.8M(+67.9%)